BridgeBio Pharma Closes $299.2 Million Financing Round To Support Its Efforts To Target Genetic Disease At The Source

Wednesday, January 23, 2019 1 min read

Key Takeaway: BridgeBio Pharma Closes $299.2 Million Financing Round To Support Its Efforts To Target Genetic Disease At The Source

Full Press Release Details

BridgeBio Pharma Closes $299.2 Million Financing Round To Support Its Efforts To Target Genetic Disease At The Source.